Merck says its experimental pill cuts COVID-19 hospitalizations and deaths by half
3 years, 2 months ago

Merck says its experimental pill cuts COVID-19 hospitalizations and deaths by half

LA Times  

Drugmaker Merck says its experimental COVID-19 pill reduced hospitalizations and deaths by half in newly infected people. Drugmaker Merck said Friday that its experimental antiviral pill cuts rates of severe disease and death in half for newly diagnosed COVID-19 patients at high risk of becoming seriously ill. Health experts from Dr. Anthony Fauci on down have long called for a convenient pill that patients could take when COVID-19 symptoms first appear, much the way the decades-old Tamiflu helps fight influenza. “It exceeded what I thought the drug might be able to do in this clinical trial,” said Dr. Dean Li, vice president of Merck Research Laboratories. Merck has also said it would license the production of molnupiravir to established generic drug manufacturers “to accelerate availability” of the pill in more than 100 low- and middle-income countries.

Results Trial Work Patients Covid Drug Fda Merck Pill Molnupiravir  pill  patients  deaths  results  hospitalizations  covid19  trial  merck  treatments  experimental  work  drug  cuts  half  molnupiravir

History of this topic

COVID-19 pills could be a game-changer, but doctors trying to use them face hurdles
2 years, 9 months ago

COVID-19 pills could be a game-changer, but doctors trying to use them face hurdles

LA Times  

Jeff Carlson, a Type 1 diabetic with heart stents, came down with COVID-19 in January, but recovered quickly after being treated with Merck’s molnupiravir. With vaccines and treatments available, “we can make this much more manageable in the future, if people are willing to take care of themselves,” said Dr. Bryan Jarabek, who helps lead COVID-19 treatment and vaccination efforts …

'Prepare for new COVID-19 variants': Joe Biden tells pandemic-weary Americans
2 years, 9 months ago

'Prepare for new COVID-19 variants': Joe Biden tells pandemic-weary Americans

Firstpost  

In his first State of the Union Address on Tuesday, Biden said thanks to the progress the country has made last year, COVID-19 need no longer controls the lives of the Americans. President Joe Biden has urged Americans to prepare themselves for new coronavirus variants as he launched a new initiative aimed at helping COVID-19-infected people to get tested at …

Covid-19 pill competing with Pfizer’s looks for quick approval in Japan
2 years, 10 months ago

Covid-19 pill competing with Pfizer’s looks for quick approval in Japan

Live Mint  

TOKYO : Drugmaker Shionogi & Co. said it plans to seek approval this month to sell its Covid-19 treatment pill in Japan after the company found that in human trials the pill had strong virus-fighting ability compared with Pfizer Inc.’s Paxlovid. Pfizer said its final-stage trial, which included more than 2,000 patients, showed Paxlovid cut the risk of hospitalization or …

WHO adds new drugs to COVID treatments amid Omicron surge
2 years, 11 months ago

WHO adds new drugs to COVID treatments amid Omicron surge

Al Jazeera  

Latest recommendations prompt new calls for patent waivers to allow more people access to treatments. The drug baricitinib, which is also used to treat rheumatoid arthritis, is “strongly recommended” for patients with severe or critical COVID-19, in combination with corticosteroids, the UN agency’s panel of international experts said in the guidelines which were published by the British Medical Journal on …

COVID-19 pill rollout stymied by shortages as omicron rages
2 years, 11 months ago

COVID-19 pill rollout stymied by shortages as omicron rages

Associated Press  

WASHINGTON — Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections. “This should be a really joyous time because we now have highly effective antiviral pills,” said Erin McCreary, a pharmacist and administrator …

COVID-19 pill rollout stymied by shortages as Omicron rages
2 years, 11 months ago

COVID-19 pill rollout stymied by shortages as Omicron rages

LA Times  

A worker handles Paxlovid pills, which are made by Pfizer to treat COVID-19. “This should be a really joyous time because we now have highly effective antiviral pills,” said Erin McCreary, a pharmacist and administrator at the University of Pittsburgh Medical Center. “Instead, this feels like the hardest and most chaotic stretch of the pandemic.” The pills — and other …

New Covid-19 pills carry risks: What patients should know
2 years, 11 months ago

New Covid-19 pills carry risks: What patients should know

Live Mint  

The first Covid-19 antiviral pills that can be taken at home are a new treatment option for infected people, but they carry safety warnings and limitations that could complicate treatment decisions for patients, doctors and pharmacists. In December, the Food and Drug Administration authorized the use of new pills from Merck & Co., with its partner Ridgeback Biotherapeutics, and Pfizer …

New easy-to-use Covid-19 pills come with a catch. Here's how
2 years, 11 months ago

New easy-to-use Covid-19 pills come with a catch. Here's how

India TV News  

Newly infected COVID-19 patients have two new treatment options that can be taken at home. The pills are intended for those with mild or moderate COVID-19 who are more likely to become seriously ill. That includes older people and those with other health conditions like heart disease, cancer or diabetes that make them more vulnerable. Antiviral pills aren't authorized for …

Live updates: Japan approves use of Merck's COVID-19 pill
3 years ago

Live updates: Japan approves use of Merck's COVID-19 pill

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy TOKYO — Japan has approved …

US adds Merck pill as 2nd easy-to-use drug against COVID-19
3 years ago

US adds Merck pill as 2nd easy-to-use drug against COVID-19

Associated Press  

WASHINGTON — U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The FDA authorized Merck’s drug for adults with a positive COVID-19 test, early symptoms and who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. Additionally, …

U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19
3 years ago

U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19

LA Times  

U.S. regulators have authorized a second pill against COVID-19: molnupiravir, an antiviral drug from Merck that may help blunt the wave of coronavirus infections. The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions such as obesity and heart disease. Additionally, …

US adds Merck pill as 2nd easy-to-use drug against Covid-19
3 years ago

US adds Merck pill as 2nd easy-to-use drug against Covid-19

India Today  

US health regulators on Thursday authorised the second pill against Covid-19, providing another easy-to-use medication to battle the rising tide of omicron infections. The Food and Drug Administration authorized Merck's drug for adults with early symptoms of Covid-19 who face the highest risks of hospitalisation, including older people and those with conditions like obesity and heart disease. Additionally, Pfizer's drug …

Merck’s at-home antiviral COVID-19 pill approved by US regulator
3 years ago

Merck’s at-home antiviral COVID-19 pill approved by US regulator

Al Jazeera  

United States health regulators have authorised a second antiviral pill against COVID-19, providing another easy-to-use medication to battle the rising tide of Omicron infections. Additionally, Pfizer’s drug was roughly three times more effective in testing than Merck’s, reducing hospitalisation and death by nearly 90 percent among high-risk patients. Merck’s drug is not authorised for use in patients younger than 18 …

Merck's Covid-19 pill Molnupiravir found to reduce hospitalisation, death risks
3 years ago

Merck's Covid-19 pill Molnupiravir found to reduce hospitalisation, death risks

India Today  

As Covid-19 cases peak across the world including the US and the UK, Molnupiravir, an oral drug developed by Merck, could act as a counter. In the phase-III clinical trials, the drug was found to reduce the risk of hospitalisation and death in at-risk, unvaccinated adults, Molnupiravir is an oral, small-molecule antiviral prodrug that is active against severe acute respiratory …

Pfizer confirms COVID pill’s results, potency versus omicron
3 years ago

Pfizer confirms COVID pill’s results, potency versus omicron

Associated Press  

WASHINGTON — Pfizer said Tuesday that its experimental pill to treat COVID-19 appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms. The Food and …

Pfizer confirms COVID pill’s results, potency versus Omicron
3 years ago

Pfizer confirms COVID pill’s results, potency versus Omicron

The Hindu  

Pfizer said on Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89% among high-risk adults when taken shortly after initial COVID-19 symptoms. The Food and Drug Administration is …

Pfizer confirms Covid pill's potency against Omicron variant
3 years ago

Pfizer confirms Covid pill's potency against Omicron variant

India Today  

Pfizer said Tuesday that its experimental Covid-19 pill appears effective against the Omicron variant. The company also said full results of its 2,250-person study confirmed the pill's promising early results against the virus: The drug reduced combined hospitalizations and deaths by about 89 per cent among high-risk adults when taken shortly after initial Covid-19 symptoms. The Food and Drug Administration …

Pfizer says its COVID-19 treatment pill works against the Omicron variant
3 years ago

Pfizer says its COVID-19 treatment pill works against the Omicron variant

LA Times  

Pfizer says its COVID-19 treatment pill appears to be effective against the Omicron variant. Pfizer said Tuesday that its experimental COVID-19 pill appears to be effective against the Omicron variant of the coronavirus. The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalizations and deaths by …

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival
3 years ago

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival

Live Mint  

Weeks after Merck & Co. scrapped development of its Covid-19 vaccines in January, one of its senior manufacturing officials began phoning his deputies, telling them their work on a pandemic shot wasn’t actually over. J&J’s unusual collaboration with a rival, and Merck’s speedy manufacturing run-up, reflect one of the biggest challenges of the pandemic: making enough Covid-19 vaccines to meet …

UK planning to rollout Merck's anti-Covid pill as soon as Christmas: Report
3 years ago

UK planning to rollout Merck's anti-Covid pill as soon as Christmas: Report

Hindustan Times  

The government in the United Kingdom is planning to roll out the antiviral pill against Coronavirus disease as part of an offered treatment against the viral disease, according to a report by Sunday Telegraph. The pill -- Molnupiravir -- has been developed by American pharmaceutical company Merck and has been touted as "game-changing" as it can be taken from the …

US panel backs first-of-a-kind COVID-19 pill from Merck
3 years ago

US panel backs first-of-a-kind COVID-19 pill from Merck

Associated Press  

WASHINGTON — A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus. The Food and Drug Administration panel voted 13-10 that the antiviral drug’s benefits outweigh its risks, including potential birth defects …

US panel backs Merck's first-of-a-kind Covid-19 pill
3 years ago

US panel backs Merck's first-of-a-kind Covid-19 pill

Hindustan Times  

A panel of US health advisers on Tuesday narrowly backed a closely watched Covid-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus. A Food and Drug Administration panel voted 13-10 that the drug’s benefits outweigh its risks, including potential birth defects if used during …

US health panel endorses Merck’s COVID-19 pill
3 years ago

US health panel endorses Merck’s COVID-19 pill

Al Jazeera  

If the FDA authorises the drug, it would be the first at-home treatment for COVID-19 two years into the pandemic. He said FDA would have to carefully tailor the drug’s use for patients who stand to benefit most. If the FDA authorises the drug, it would be the first at-home treatment for the virus nearly two years into the pandemic. …

Merck’s covid-19 pill to be reviewed by FDA advisers
3 years ago

Merck’s covid-19 pill to be reviewed by FDA advisers

Live Mint  

An outside panel of scientific advisers to the Food and Drug Administration is scheduled to meet Tuesday to discuss the experimental Covid-19 oral antiviral from Merck & Co. and partner Ridgeback Biotherapeutics LP. Researchers plan to study molnupiravir and Omicron soon but think the drug could be effective because it has been found to work against other Covid-19 variants, the …

New antiviral drugs are coming for COVID. Here's what you need to know
3 years ago

New antiviral drugs are coming for COVID. Here's what you need to know

NPR  

New antiviral drugs are coming for COVID. Given the higher efficacy of the antibody treatments, "I think we will continue to use those, particularly for high risk people," says Dr. Rajesh Gandhi, an infectious diseases physician at Massachusetts General Hospital and Harvard Medical School who serves on COVID-19 Treatment Guidelines Panels for the NIH and the Infectious Diseases Society of …

FDA: Merck COVID pill effective, experts will review safety
3 years ago

FDA: Merck COVID pill effective, experts will review safety

Associated Press  

Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy. Additionally, the FDA flagged a concern that Merck’s drug led to small changes in the coronavirus’ signature spike protein, which it uses to penetrate human cells. …

Merck’s COVID pill shows lower efficacy in updated study
3 years ago

Merck’s COVID pill shows lower efficacy in updated study

Al Jazeera  

Drugmaker says final analysis of trial results showed molnupiravir led to 30 percent reduction in hospitalisations and deaths, compared with about 50 percent in interim study. Drugmaker Merck’s experimental COVID-19 pill is significantly less effective in slashing hospitalisations and deaths than previously reported, the company has said, following the release of a full analysis of trial results. The United States-based …

Merck asks EU drug regulator to authorise its Covid-19 pill
3 years, 1 month ago

Merck asks EU drug regulator to authorise its Covid-19 pill

Hindustan Times  

The European Medicines Agency said it has received a request from Merck to authorise its coronavirus antiviral, the first pill shown to treat Covid-19. In a statement Tuesday, the EU drug regulator said it had started evaluating molnupiravir, made by Merck and Ridgeback Biotherapeutics, and that a decision could be made within weeks on whether it might be cleared. Last …

EU regulator recommends Merck’s COVID-19 pill for emergency use
3 years, 1 month ago

EU regulator recommends Merck’s COVID-19 pill for emergency use

Al Jazeera  

The European Union’s medicines watchdog has advised its member states they can use a potentially groundbreaking COVID-19 antiviral pill in emergency situations triggered by soaring infection rates, ahead of the treatment’s formal approval across the bloc. Molnupiravir, which is produced by Merck and Ridgeback Biotherapeutics, can be given within five days of first symptoms to treat adults who do not …

Finally, pills to treat Covid-19! All you need to know about Pfizer's Paxlovid and Merck's Molnupiravir
3 years, 1 month ago

Finally, pills to treat Covid-19! All you need to know about Pfizer's Paxlovid and Merck's Molnupiravir

India Today  

Vaccines have been the primary antidote in the battle against Covid-19 to date, but we could have at least two game-changers in the form of American pharmaceutical giant Pfizer's antiviral pill Paxlovid, and Molnupiravir, manufactured by Merck, Sharp and Dohme, and Ridgeback Biotherapeutics. The preliminary data of Pfizer's experimental antiviral pill to treat Covid-19 shows an 89 per cent decrease …

Pfizer says COVID-19 pill cut hospital, death risk by 90%
3 years, 1 month ago

Pfizer says COVID-19 pill cut hospital, death risk by 90%

Associated Press  

WASHINGTON — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on …

Pfizer says Covid-19 pill is 89% effective in preliminary assessment
3 years, 1 month ago

Pfizer says Covid-19 pill is 89% effective in preliminary assessment

Live Mint  

Pfizer Inc. said a preliminary look at study results indicated that its experimental pill was highly effective at preventing people at high risk of severe Covid-19 from needing hospitalization or dying, the latest encouraging performance for an early virus treatment. The company’s drug cut the risk of hospitalization or death in study subjects with mild to moderate Covid-19 by about …

Britain becomes first country to approve Merck's Covid-19 pill molnupiravir
3 years, 1 month ago

Britain becomes first country to approve Merck's Covid-19 pill molnupiravir

India Today  

Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck & Co Inc and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic. Britain's Medicines and Healthcare products Regulatory Agency recommended the drug, molnupiravir, for use in people with mild to moderate COVID-19 and at …

Pfizer says its COVID-19 pill cuts hospitalisations, death by 89%
3 years, 1 month ago

Pfizer says its COVID-19 pill cuts hospitalisations, death by 89%

Al Jazeera  

Pharmaceutical companies are in a race to manufacture easy-to-use medication against the coronavirus. Pfizer has said its experimental antiviral pill for COVID-19 cuts risk rates of hospitalisation and death by nearly 90 percent, as drugmakers race to manufacture easy-to-use medication against the coronavirus. Of those given Pfizer’s drug within three days of symptom onset 0.8 percent were hospitalised and none …

UK approves Merck's antiviral COVID pill molnupiravir in world first
3 years, 1 month ago

UK approves Merck's antiviral COVID pill molnupiravir in world first

ABC  

Britain has become the first country in the world to approve Merck's potentially game-changing COVID-19 antiviral pill. Key points: US advisers will meet this month to vote on whether molnupiravir should be authorised Australia has already ordered 300,000 courses Merck is expecting to produce 10 million courses by the end of this year The UK's Medicines and Healthcare products Regulatory …

UK authorizes Merck antiviral pill, 1st shown to treat COVID
3 years, 1 month ago

UK authorizes Merck antiviral pill, 1st shown to treat COVID

Associated Press  

LONDON — Britain granted conditional authorization on Thursday to the first pill shown to successfully treat COVID-19 so far. The U.S. Food and Drug Administration announced last month it would convene a panel of independent experts to scrutinize the pill’s safety and effectiveness in late November. Merck announced preliminary results in September showing its drug cut hospitalizations and deaths by …

UK becomes first country to approve Merck's anti-Covid pill molnupiravir
3 years, 1 month ago

UK becomes first country to approve Merck's anti-Covid pill molnupiravir

Hindustan Times  

Britain on Thursday approved the use of Merck's antiviral pill to treat patients suffering from mild to moderate Covid-19, the Medicines and Healthcare products Regulatory Agency announced. Based on the clinical trial data, the drug is most effective when taken during the early stages of infection and the MHRA recommends that it be used within five days of the onset …

UK approves Merck’s antiviral COVID-19 pill in world first move
3 years, 1 month ago

UK approves Merck’s antiviral COVID-19 pill in world first move

Al Jazeera  

Merck’s molnupiravir to be given to recently-infected COVID-19 patients twice a day, for five days. The United Kingdom has become the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics. Merck’s molnupiravir has been closely watched since data last month showed it could halve the chances of dying or …

Britain becomes the first nation to authorize Merck’s COVID-19 pill
3 years, 1 month ago

Britain becomes the first nation to authorize Merck’s COVID-19 pill

LA Times  

So far Merck’s COVID-19 pill is the only one shown to successfully treat the disease. Britain has granted conditional authorization to Merck’s COVID-19 pill — the only one so far shown to successfully treat the disease — becoming the first nation to OK the treatment, although it was not immediately clear how quickly the drug would be available. Merck and …

Molnupiravir: UK authorizes Merck/Ridgeback Biotherapeutics’ antiviral to treat mild-to-moderate Covid-19
3 years, 1 month ago

Molnupiravir: UK authorizes Merck/Ridgeback Biotherapeutics’ antiviral to treat mild-to-moderate Covid-19

CNN  

CNN — The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics’ oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness. The companies have sought US Food and Drug Administration emergency use authorization for the drug, and the FDA said it will convene its Antimicrobial Drugs Advisory Committee …

Merck Covid pill: Asian countries are rushing to buy molnupiravir but poor countries could miss out
3 years, 2 months ago

Merck Covid pill: Asian countries are rushing to buy molnupiravir but poor countries could miss out

CNN  

CNN — During the global scramble to secure vaccines, many countries in Asia-Pacific were slow off the mark. “This is a game changer.” What the Covid pill means for vaccines Vaccines are still the best protection, say experts – after all, they can reduce the risk of a person getting Covid-19 at all. “This drug will be a frontline solution …

Merck seeks first US authorization for Covid-19 tablet
3 years, 2 months ago

Merck seeks first US authorization for Covid-19 tablet

Live Mint  

Merck & Co Inc said on Monday it has applied for US emergency use authorization for its tablet to treat mild-to-moderate patients of COVID-19, putting it on course to become the first oral antiviral medication for the disease. An authorization from the US Food and Drug Administration could help change clinical management of COVID-19 as the pill can be taken …

Merck seeks FDA emergency use authorization for experimental antiviral Covid-19 treatment molnupiravir
3 years, 2 months ago

Merck seeks FDA emergency use authorization for experimental antiviral Covid-19 treatment molnupiravir

CNN  

CNN — Merck said Monday it is seeking US Food and Drug Administration emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir. “At the interim analysis, molnupiravir reduced the risk of hospitalization or death by approximately 50%; 7.3% of patients who received molnupiravir were either hospitalized or died through Day 29 following randomization, compared with 14.1% of placebo-treated patients,” …

Merck seeks US authorisation for pill to treat COVID
3 years, 2 months ago

Merck seeks US authorisation for pill to treat COVID

Al Jazeera  

US pharmaceutical giant submits request for FDA approval for molnupiravir pill to treat mild-to-moderate COVID-19 cases. US pharmaceutical company Merck has requested emergency authorisation for its experimental pill to treat mild-to-moderate cases of COVID-19, in what would add a promising, new tool to the global fight against the virus. Merck submitted the application for molnupiravir, which it said earlier this …

EXPLAINED: A Pill You Can Pop At Home To Beat Covid. Here's Why Merck's Antiviral Drug Is Raising Hopes
3 years, 2 months ago

EXPLAINED: A Pill You Can Pop At Home To Beat Covid. Here's Why Merck's Antiviral Drug Is Raising Hopes

News 18  

The global death toll from Covid-19 is said to now have crossed 5 million even as the pandemic’s end is yet to appear within sight. Merck, which has partnered the US-based Ridgeback Biotherapeutics for the development of the drug, said that Phase-3 trials showed that it “significantly reduced the risk of hospitalisation or death… in at risk, non-hospitalised adult patients …

Explained | Molnupiravir, Merck’s new drug to treat COVID-19
3 years, 2 months ago

Explained | Molnupiravir, Merck’s new drug to treat COVID-19

The Hindu  

Why is there much excitement about molnupiravir, the investigational new drug for COVID-19? Pharmaceutical major Merck and Ridgeback Biotherapeutics announced via a press release on October 1 the early results from Phase-3 trials that its anti-viral drug molnupiravir halved the chances of hospitalisation in COVID-19 patients with mild or moderate disease. Several noted clinicians have said that these are promising …

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid
3 years, 2 months ago

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid

News 18  

Merck’s Molnupiravir, Zydus’ antibody cocktail and Glenmark’s nasal spray are among more than 20 new drugs in different stages of drug trials or approvals in India to treat Covid-19. “As the world needs Covid-19 vaccines, the world also needs proven and effective Covid-19 therapies,” Lahariya said. List of Drugs in the Pipeline US pharma giant Merck and Ridgeback Biotherapeutics’ oral …

US hits 700,000 COVID deaths just as cases begin to fall
3 years, 2 months ago

US hits 700,000 COVID deaths just as cases begin to fall

India TV News  

The United States reached its latest heartbreaking pandemic milestone Friday, eclipsing 700,000 deaths from COVID-19 just as the surge from the delta variant is starting to slow down and give overwhelmed hospitals some relief. “You lose patients from COVID and it should not happen,” said Debi Delapaz, a nurse manager at UF Health Jacksonville who recalled how the hospital was …

US hits 700,000 COVID deaths just as cases begin to fall
3 years, 2 months ago

US hits 700,000 COVID deaths just as cases begin to fall

Associated Press  

MINNEAPOLIS — The United States reached its latest heartbreaking pandemic milestone Friday, eclipsing 700,000 deaths from COVID-19 just as the surge from the delta variant is starting to slow down and give overwhelmed hospitals some relief. “You lose patients from COVID and it should not happen,” said Debi Delapaz, a nurse manager at UF Health Jacksonville who recalled how the …

US coronavirus: Antiviral pill could be a game changer, but vaccines are still America’s way out of the pandemic, experts say
3 years, 2 months ago

US coronavirus: Antiviral pill could be a game changer, but vaccines are still America’s way out of the pandemic, experts say

CNN  

CNN — A pill that could potentially treat Covid-19 is a “game-changer,” but experts are emphasizing that it’s not an alternative to vaccinations – which remain the most effective path to ending the coronavirus pandemic if enough people get their shots. “I think getting an oral pill that can inhibit viral replication – that can inhibit this virus – is …

Discover Related